Ameliorative effects of Cirsium japonicum extract and main component cirsimaritin in mice model of high‐fat diet‐induced metabolic dysfunction‐associated fatty liver disease
| Autor: | Byoung Ok Cho, Jae Young Shin, Hyun Ju Kang, Dong Jun Sim, Ji Hyeon Park, Jae Suk Sim, Feng Wang, Denis Nchang Che, Seon Il Jang, Suping Hao |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Cirrhosis
Cirsimaritin MAFLD Pharmacology medicine.disease_cause chemistry.chemical_compound Fibrosis medicine oxidative stress TX341-641 Original Research fatty liver Liver injury Triglyceride business.industry Nutrition. Foods and food supply Fatty liver medicine.disease Malondialdehyde Cirsium japonicum chemistry inflammation Steatosis business Oxidative stress Food Science |
| Zdroj: | Food Science & Nutrition, Vol 9, Iss 11, Pp 6060-6068 (2021) Food Science & Nutrition |
| ISSN: | 2048-7177 |
| Popis: | The objective of this study was to determine biological effects of Cirsium japonicum extract and its main component cirsimaritin on high‐fat diet (HFD)‐induced metabolic dysfunction‐associated fatty liver disease (MAFLD) in a mouse model. Mice were fed with a HFD to induce MAFLD and simultaneously administered with C. japonicum extract (CJE) or cirsimaritin. Various MAFLD biomarkers were evaluated using biological methods. Results demonstrated that triglyceride, aspartate aminotransferase, alanine aminotransferase, and malondialdehyde levels in the liver of mice were significantly reduced upon administration of CJE or cirsimaritin. Treatment with CJE or cirsimaritin also reduced the severity of liver injury in the experimental mouse model of MAFLD by inhibiting hepatic steatosis, oxidative stress, inflammation, and liver fibrosis. These results demonstrate that CJE and cirsimaritin as its main compound have a preventive action against the progression of hepatic steatosis to fibrosis and cirrhosis. Our study suggests that CJE and cirsimaritin might be promising agents for preventing and/or treating MAFLD. Cirsium japonicum and Cir improved HFD‐induced MAFLD through inhibition of hepatic steatosis, oxidative stress, and inflammation. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|